FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2550658566> ?p ?o ?g. }

• W2550658566 abstract "Abstract Abstract 1113 In this study, we investigated the molecular basis of upregulation of factor VII (FVII) gene expression by ribavirin, and found that intracellular GTP depletion induced by ribavirin activated FVII gene transcription and modulated transcription elongation. In 2006, Yamamoto et al. reported that anti-hepatitis C virus (HCV) agent ribavirin elevated the activity of FVII in HCV-infected hemophilia patients; however, the precise mechanisms were still unknown. In addition, the anti-HCV mechanisms of ribavirin were not yet fully elucidated, although the extended studies have been done. We investigated the effects of ribavirin in vitro and confirmed the approximately 4-fold upregulation of FVII mRNA by ribavirin treatment in HepG2 cells. FVII mRNA was increased in a dose-dependent manner up to 100μg/mL of ribavirin at a lower concentration than therapeutic concentration of 150μg/mL. FVII mRNA induction by ribavirin was also observed in a time-dependent manner from 24 h to 72 h after treatment. Ribavirin metabolite ribavirin 5'-monophosphate is one of the IMP dehydrogenase (IMPDH) inhibitors, and the other IMPDH inhibitors mycophenolic acid (MPA) and 6-mercaptupurine (6-MP) also induced FVII upregulation. It is well known that inhibition of IMPDH causes intracellular GTP depletion, and guanosine supplementation to salvage GTP could reverse FVII mRNA increase in ribavirin-treated cells. These results indicated that cellular GTP reduction associated with FVII gene upregulation. The mechanisms of gene upregulation by GTP depletion were not elucidated. The promoter activities and mRNA stability of FVII were analyzed under ribavirin treatment. The FVII gene promoter activity was enhanced up to 1.5-fold by ribavirin treatment; however the activation did not reach 4-fold induction of FVII mRNA increase. There was no significant change of FVII mRNA half-life in ribavirin-treated cells. Since the promoter activation might display transcription initiation capacity, the contribution of transcription elongation stage was further investigated. Transcription elongation was regulated by phosphorylation of carbo-terminal domain (CTD) of RNA polymerase II (PolII). Transcription elongation factor P-TEFb (positive-transcription elongation factor b), which consists as a complex of CDK9 and cyclin T, phosphorylates Ser of PolII CTD. The kinase activity of P-TEFb could be inhibited by 5,6-dichlorobenzimidazole 1-b-D-ribofuranoside (DRB). In FVII gene upregulation, DRB completely canceled ribavirin-induced FVII mRNA increase. We also performed nuclear run-on assay to verify the potential transcription elongation capacity of paused PolII, and observed a dramatic increase of FVII mRNA in ribavirin-treated cells. These results suggested that ribavirin-induced FVII gene upregulation was caused not only by transcription initiation but also by accelerated transcription elongation rate. There are various transcription factor associated with transcription elongation in addition to P-TEFb, such as elongin, ELL (eleven nineteen-lysine rich leukemia). We found that ELL3, a member of ELL family protein, was upregulated by ribavirin treatment. A ELL3 mRNA increase occurred prior to FVII mRNA upregulation, and the ELL3 upregulation was also canceled by guanosine supplementation. These results indicated ELL3 induction by ribavirin was also a response to cellular GTP depletion. To confirm the contribution of ELL3 protein to FVII gene transcription elongation, we used siRNAs specific to ELL3 and as expected, knockdown of ELL3 resulted in diminished FVII upregulation. A chromatin immunoprecipitation (ChIP) revealed ELL3 recruitment to the FVII gene, and the recruitments of PolII and CDK9 were also enhanced by ribavirin treatment. Taken together, FVII gene upregulation by ribavirin was associated with intracellular GTP depletion. The GTP reduction mainly modulates transcription elongation rate rather than transcription initiation, though the relationships between cellular GTP depletion and enhanced transcription elongation must be investigated. This study uncovered candidate mechanisms of ribavirin and the other IMPDH inhibitors and highlights a development of novel pharmaceutical therapies for hemophilia. Disclosures: No relevant conflicts of interest to declare." @default.
• W2550658566 created "2016-11-30" @default.
• W2550658566 creator A5004757783 @default.
• W2550658566 creator A5012540173 @default.
• W2550658566 creator A5016568750 @default.
• W2550658566 creator A5025336375 @default.
• W2550658566 creator A5029208154 @default.
• W2550658566 creator A5035081766 @default.
• W2550658566 creator A5048728556 @default.
• W2550658566 creator A5050087202 @default.
• W2550658566 creator A5072103381 @default.
• W2550658566 creator A5082094608 @default.
• W2550658566 creator A5086292928 @default.
• W2550658566 date "2012-11-16" @default.
• W2550658566 modified "2023-10-01" @default.
• W2550658566 title "Ribavirin-Induced Intracellular GTP Depletion Upregulates Factor VII Expression" @default.
• W2550658566 doi "https://doi.org/10.1182/blood.v120.21.1113.1113" @default.
• W2550658566 hasPublicationYear "2012" @default.
• W2550658566 type Work @default.
• W2550658566 sameAs 2550658566 @default.
• W2550658566 citedByCount "0" @default.
• W2550658566 crossrefType "journal-article" @default.
• W2550658566 hasAuthorship W2550658566A5004757783 @default.
• W2550658566 hasAuthorship W2550658566A5012540173 @default.
• W2550658566 hasAuthorship W2550658566A5016568750 @default.
• W2550658566 hasAuthorship W2550658566A5025336375 @default.
• W2550658566 hasAuthorship W2550658566A5029208154 @default.
• W2550658566 hasAuthorship W2550658566A5035081766 @default.
• W2550658566 hasAuthorship W2550658566A5048728556 @default.
• W2550658566 hasAuthorship W2550658566A5050087202 @default.
• W2550658566 hasAuthorship W2550658566A5072103381 @default.
• W2550658566 hasAuthorship W2550658566A5082094608 @default.
• W2550658566 hasAuthorship W2550658566A5086292928 @default.
• W2550658566 hasConcept C104317684 @default.
• W2550658566 hasConcept C118716 @default.
• W2550658566 hasConcept C126322002 @default.
• W2550658566 hasConcept C127561419 @default.
• W2550658566 hasConcept C153911025 @default.
• W2550658566 hasConcept C159047783 @default.
• W2550658566 hasConcept C181199279 @default.
• W2550658566 hasConcept C185592680 @default.
• W2550658566 hasConcept C2522874641 @default.
• W2550658566 hasConcept C2776408679 @default.
• W2550658566 hasConcept C2777995097 @default.
• W2550658566 hasConcept C2778033501 @default.
• W2550658566 hasConcept C2780040827 @default.
• W2550658566 hasConcept C2911091166 @default.
• W2550658566 hasConcept C38596361 @default.
• W2550658566 hasConcept C55493867 @default.
• W2550658566 hasConcept C71924100 @default.
• W2550658566 hasConcept C79879829 @default.
• W2550658566 hasConcept C86803240 @default.
• W2550658566 hasConceptScore W2550658566C104317684 @default.
• W2550658566 hasConceptScore W2550658566C118716 @default.
• W2550658566 hasConceptScore W2550658566C126322002 @default.
• W2550658566 hasConceptScore W2550658566C127561419 @default.
• W2550658566 hasConceptScore W2550658566C153911025 @default.
• W2550658566 hasConceptScore W2550658566C159047783 @default.
• W2550658566 hasConceptScore W2550658566C181199279 @default.
• W2550658566 hasConceptScore W2550658566C185592680 @default.
• W2550658566 hasConceptScore W2550658566C2522874641 @default.
• W2550658566 hasConceptScore W2550658566C2776408679 @default.
• W2550658566 hasConceptScore W2550658566C2777995097 @default.
• W2550658566 hasConceptScore W2550658566C2778033501 @default.
• W2550658566 hasConceptScore W2550658566C2780040827 @default.
• W2550658566 hasConceptScore W2550658566C2911091166 @default.
• W2550658566 hasConceptScore W2550658566C38596361 @default.
• W2550658566 hasConceptScore W2550658566C55493867 @default.
• W2550658566 hasConceptScore W2550658566C71924100 @default.
• W2550658566 hasConceptScore W2550658566C79879829 @default.
• W2550658566 hasConceptScore W2550658566C86803240 @default.
• W2550658566 hasLocation W25506585661 @default.
• W2550658566 hasOpenAccess W2550658566 @default.
• W2550658566 hasPrimaryLocation W25506585661 @default.
• W2550658566 hasRelatedWork W1514616303 @default.
• W2550658566 hasRelatedWork W1983470607 @default.
• W2550658566 hasRelatedWork W1992865315 @default.
• W2550658566 hasRelatedWork W2001505809 @default.
• W2550658566 hasRelatedWork W2002830209 @default.
• W2550658566 hasRelatedWork W2013518995 @default.
• W2550658566 hasRelatedWork W2023640290 @default.
• W2550658566 hasRelatedWork W2042518710 @default.
• W2550658566 hasRelatedWork W2059288162 @default.
• W2550658566 hasRelatedWork W2076355513 @default.
• W2550658566 hasRelatedWork W2078451092 @default.
• W2550658566 hasRelatedWork W2127134544 @default.
• W2550658566 hasRelatedWork W2127223166 @default.
• W2550658566 hasRelatedWork W2133040712 @default.
• W2550658566 hasRelatedWork W2147482684 @default.
• W2550658566 hasRelatedWork W2164440257 @default.
• W2550658566 hasRelatedWork W2255062718 @default.
• W2550658566 hasRelatedWork W2415576090 @default.
• W2550658566 hasRelatedWork W2883116612 @default.
• W2550658566 hasRelatedWork W632403431 @default.
• W2550658566 isParatext "false" @default.
• W2550658566 isRetracted "false" @default.
• W2550658566 magId "2550658566" @default.
• W2550658566 workType "article" @default.